Thrombocytopenia and hyperthyroidism: A case report and literature review

Key Clinical Message Immune thrombocytopenic purpura (ITP) is very challenging to diagnose with concurrent comorbidities affecting platelet count including PAH and autoimmune thyroid disease. ITP resolution can be achieved with tailored treatment of the underlying conditions to avoid adverse events....

Full description

Bibliographic Details
Main Authors: Pitchaporn Yingchoncharoen, Mahmoud Abdelnabi, Jerapas Thongpiya, Alexandra Hoffman, Hira Tariq, Neha Mittal
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.7960
_version_ 1797650438962544640
author Pitchaporn Yingchoncharoen
Mahmoud Abdelnabi
Jerapas Thongpiya
Alexandra Hoffman
Hira Tariq
Neha Mittal
author_facet Pitchaporn Yingchoncharoen
Mahmoud Abdelnabi
Jerapas Thongpiya
Alexandra Hoffman
Hira Tariq
Neha Mittal
author_sort Pitchaporn Yingchoncharoen
collection DOAJ
description Key Clinical Message Immune thrombocytopenic purpura (ITP) is very challenging to diagnose with concurrent comorbidities affecting platelet count including PAH and autoimmune thyroid disease. ITP resolution can be achieved with tailored treatment of the underlying conditions to avoid adverse events. Abstract Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a platelet count of <100 × 109/L in the absence of other causes of thrombocytopenia. It is classified as primary or idiopathic and secondary due to various coexisting conditions, including autoimmune thyroid diseases. It is especially challenging when the patient has comorbidities that affect platelet count easily, leading to anchoring bias. The first‐line treatment of ITP is corticosteroids, and it is also recommended to treat the primary causes of secondary ITP. Here, the authors report a case of secondary ITP in a patient with a recent diagnosis of Grave's disease and a history of idiopathic pulmonary hypertension with baseline chronic thrombocytopenia, possible mechanisms, and treatment strategies with a multidisciplinary approach.
first_indexed 2024-03-11T16:00:23Z
format Article
id doaj.art-cf7e0466cc314acb869e19facebc67c4
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-03-11T16:00:23Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-cf7e0466cc314acb869e19facebc67c42023-10-25T07:12:44ZengWileyClinical Case Reports2050-09042023-10-011110n/an/a10.1002/ccr3.7960Thrombocytopenia and hyperthyroidism: A case report and literature reviewPitchaporn Yingchoncharoen0Mahmoud Abdelnabi1Jerapas Thongpiya2Alexandra Hoffman3Hira Tariq4Neha Mittal5Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USADepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USADepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USADepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USAShalamar Institute of Health Sciences Lahore PakistanDepartment of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USAKey Clinical Message Immune thrombocytopenic purpura (ITP) is very challenging to diagnose with concurrent comorbidities affecting platelet count including PAH and autoimmune thyroid disease. ITP resolution can be achieved with tailored treatment of the underlying conditions to avoid adverse events. Abstract Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a platelet count of <100 × 109/L in the absence of other causes of thrombocytopenia. It is classified as primary or idiopathic and secondary due to various coexisting conditions, including autoimmune thyroid diseases. It is especially challenging when the patient has comorbidities that affect platelet count easily, leading to anchoring bias. The first‐line treatment of ITP is corticosteroids, and it is also recommended to treat the primary causes of secondary ITP. Here, the authors report a case of secondary ITP in a patient with a recent diagnosis of Grave's disease and a history of idiopathic pulmonary hypertension with baseline chronic thrombocytopenia, possible mechanisms, and treatment strategies with a multidisciplinary approach.https://doi.org/10.1002/ccr3.7960autoimmune diseaseGrave's diseaseimmune thrombocytopeniapulmonary arterial hypertensionthyroid disease
spellingShingle Pitchaporn Yingchoncharoen
Mahmoud Abdelnabi
Jerapas Thongpiya
Alexandra Hoffman
Hira Tariq
Neha Mittal
Thrombocytopenia and hyperthyroidism: A case report and literature review
Clinical Case Reports
autoimmune disease
Grave's disease
immune thrombocytopenia
pulmonary arterial hypertension
thyroid disease
title Thrombocytopenia and hyperthyroidism: A case report and literature review
title_full Thrombocytopenia and hyperthyroidism: A case report and literature review
title_fullStr Thrombocytopenia and hyperthyroidism: A case report and literature review
title_full_unstemmed Thrombocytopenia and hyperthyroidism: A case report and literature review
title_short Thrombocytopenia and hyperthyroidism: A case report and literature review
title_sort thrombocytopenia and hyperthyroidism a case report and literature review
topic autoimmune disease
Grave's disease
immune thrombocytopenia
pulmonary arterial hypertension
thyroid disease
url https://doi.org/10.1002/ccr3.7960
work_keys_str_mv AT pitchapornyingchoncharoen thrombocytopeniaandhyperthyroidismacasereportandliteraturereview
AT mahmoudabdelnabi thrombocytopeniaandhyperthyroidismacasereportandliteraturereview
AT jerapasthongpiya thrombocytopeniaandhyperthyroidismacasereportandliteraturereview
AT alexandrahoffman thrombocytopeniaandhyperthyroidismacasereportandliteraturereview
AT hiratariq thrombocytopeniaandhyperthyroidismacasereportandliteraturereview
AT nehamittal thrombocytopeniaandhyperthyroidismacasereportandliteraturereview